T1	PrimaryOutcome 34 121	time to achieve a negative RT-PCR result for SARS-CoV-2 in a nasopharyngeal swab sample
T2	SecondaryOutcome 157 187	time to resolution of symptoms
T3	OutcomeDefinition 199 231	a NEWS2 of 0 maintained for 24 h
R1	DefinedAs Arg1:T2 Arg2:T3	
T4	SecondaryOutcome 239 297	NEWS2 and sequential organ failure assessment (SOFA) score
T5	SecondaryOutcome 299 322	length of hospital stay
T6	SecondaryOutcome 335 344	mortality
T7	OtherOutcome 387 453	time to achieve negative SARS-CoV-2 RT-PCR in all clinical samples
T8	OtherOutcome 549 573	daily viral load changes
T9	TimeFrame 574 593	in the first 7 days
R2	MeasuredAt Arg1:T8 Arg2:T9	
T10	OtherOutcome 599 677	emergence of amino acid mutations in the nsp5 gene encoding a 3C-like protease
T11	OtherOutcome 752 794	frequencies and duration of adverse events
T12	TimeFrame 328 334	30-day
T13	OutcomeDefinition 465 547	nasopharyngeal swab, posterior oropharyngeal saliva, throat swab, stool, and urine
R3	DefinedAs Arg1:T7 Arg2:T13	
T14	OtherOutcome 683 706	serum cytokine response
R4	MeasuredAt Arg1:T6 Arg2:T12	
T15	TimeFrame 233 238	daily
R5	MeasuredAt Arg1:T4 Arg2:T15	
